Tacedinaline, also known as CI-994, is a class I histone deacetylase (HDAC) inhibitor, which has been found to induce apoptosis, and growth arrest in preclinical models of AML and non-small cell lung cancer cell lines [82,83]. Here, HDAC9 is linked to acute myeloid leukemia.